Ledger.Open graph →
SEC Form D · filed June 21, 2018

AgeX Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ALAMEDA, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Russell D. Skibsted · Alameda, CAExecMichael H. Mulroy · Alameda, CADirectorMichael D. West · Alameda, CAExec · DirectorBioTime, Inc · Alameda, CAPromoterAlfred D. Kingsley · New York, NYExec · DirectorJohn F. Mauldin · Alameda, CADirectorThomas T. Suminski · Northbrook, ILDirectorEric L. Langford · DALLAS, TXExecPatrick L. Howard · DALLAS, TXPromoterSteven B. Clapp · DALLAS, TXExec · DirectorThomas L. Mcdougal · DALLAS, TXDirectorStanley H. Pantowich · New York, NYExec · DirectorHeini Zachariassen · San Francisco, CADirectorNeeraj Arora · San Francisco, CAExecMatt Gibbs · Fort Collins, COPromoterBob J. Gibbs · Fort Collins, COExec · DirectorNiraj Gupta · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗